Status:
TERMINATED
Pain Using Reduced Fluence Parameters in Photocoagulation for Diabetic Retinopathy.
Lead Sponsor:
Asociación para Evitar la Ceguera en México
Conditions:
Proliferative Diabetic Retinopathy
Eligibility:
All Genders
18-80 years
Phase:
PHASE4
Brief Summary
The used of reduced fluence parameters for panretinal photocoagulation decreases pain as perceived by the patient, compared to traditional parameters.
Eligibility Criteria
Inclusion
- Patients 18 years or older, that signed informed consent
- Proliferative diabetic retinopathy with indication for panretinal photocoagulation
Exclusion
- Previous retinal photocoagulation
- Previous ocular surgical procedures
- Ocular media opacities
- History of trigeminal neuralgia
- Chronic ocular pain
- Depression under conductual or medical treatment
Key Trial Info
Start Date :
March 1 2008
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
November 1 2008
Estimated Enrollment :
25 Patients enrolled
Trial Details
Trial ID
NCT00802269
Start Date
March 1 2008
End Date
November 1 2008
Last Update
May 30 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Asociacion para Evitar la Ceguera en Mexico
Mexico City, Mexico City, Mexico, 04030